Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > Geopolitical conundrum, Plut?......
View:
Post by ISAloser247 on Nov 24, 2010 11:46am

Geopolitical conundrum, Plut?......


......checked out the Shenyang Sunshine Pharmaceutical site(3SBio,on this side of the Pacific), Plut.

In a newsletter for product RhTPO(injectable recombinant erythropoietin) "This project has been paid much attention and was supported by our national and local government.  This project was also listed into the national '863' plan and 'Ten-Five' specialized project."  Makes You wonder Who is going to be pulling the strings as an 18.8% owner, and with
the Korean conglomerate coming in as a majority owner,  and the VERY CURRENT ESCALATION IN THE KOREAN
ZONE,  is there any voclo future?

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities